Every intensivist recognizes that families play a prominent role in ICU decision making.
Sickle cell disease is a common condition seen throughout the spectrum of ages. Emergency department (ED) physicians must be aware of the range of presentations and the vulnerability of these patients to certain clinical conditions.
Many clinical trials have confirmed the benefit of early invasive therapy for high-risk patients presenting with acute coronary syndromes (ACS). However, the optimal timing of cardiac catheterization in this group remains unknown.
This retrospective cohort study reaffirms the link between hyperglycemia and mortality in the ICU, but demonstrates that the risk does not apply equally to all patient groups and, instead, varies based on admission diagnosis.
